Literature DB >> 26833930

Structural brain correlates of cognitive and behavioral impairment in MND.

Federica Agosta1, Pilar M Ferraro1, Nilo Riva2, Edoardo G Spinelli1,2, Adriano Chiò3, Elisa Canu1, Paola Valsasina1, Christian Lunetta4, Sandro Iannaccone5, Massimiliano Copetti6, Evelina Prudente1,7, Giancarlo Comi2, Andrea Falini4, Massimo Filippi1,2.   

Abstract

OBJECTIVE: To assess the structural correlates of cognitive and behavioral impairment in motor neuron diseases (MND) using multimodal MRI.
METHODS: One hundred one patients with sporadic MND (56 classic amyotrophic lateral sclerosis, 31 upper motor neuron phenotype, and 14 lower motor neuron phenotype) and 51 controls were enrolled. Patients were classified into MND with a pure motor syndrome (MND-motor) and with cognitive/behavioral symptoms (MND-plus). Cortical thickness measures and diffusion tensor (DT) metrics of white matter (WM) tracts were assessed. A random forest approach was used to explore the independent role of cortical and WM abnormalities in explaining major cognitive and behavioral symptoms.
RESULTS: There were 48 MND-motor and 53 MND-plus patients. Relative to controls, both patient groups showed a distributed cortical thinning of the bilateral precentral gyrus, insular and cingulate cortices, and frontotemporal regions. In all regions, there was a trend toward a more severe involvement in MND-plus cases, particularly in the temporal lobes. Both patient groups showed damage to the motor callosal fibers, which was more severe in MND-plus. MND-plus patients also showed a more severe involvement of the extra-motor WM tracts. The best predictors of executive and non-executive deficits and behavioral symptoms in MND were diffusivity abnormalities of the corpus callosum and frontotemporal tracts, including the uncinate, cingulum, and superior longitudinal fasciculi.
CONCLUSIONS: Cortical thinning and WM degeneration are highly associated with neuropsychological and behavioral symptoms in patients with MND. DT MRI metrics seem to be the most sensitive markers of extra-motor deficits within the MND spectrum.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  amyotrophic lateral sclerosis; cognitive and behavioral impairment; cortical thinning; diffusion tensor MRI; motor neuron disease

Mesh:

Year:  2016        PMID: 26833930      PMCID: PMC6867462          DOI: 10.1002/hbm.23124

Source DB:  PubMed          Journal:  Hum Brain Mapp        ISSN: 1065-9471            Impact factor:   5.038


  67 in total

1.  Mapping eddy current induced fields for the correction of diffusion-weighted echo planar images.

Authors:  M A Horsfield
Journal:  Magn Reson Imaging       Date:  1999-11       Impact factor: 2.546

2.  Neuroanatomical correlates of apathy in ALS using 4 Tesla diffusion tensor MRI.

Authors:  Susan C Woolley; Yu Zhang; Norbert Schuff; Michael W Weiner; Jonathan S Katz
Journal:  Amyotroph Lateral Scler       Date:  2011-01

3.  Cortical thinning and its relation to cognition in amyotrophic lateral sclerosis.

Authors:  Christina Schuster; Elisabeth Kasper; Martin Dyrba; Judith Machts; Daniel Bittner; Jörn Kaufmann; Alex J Mitchell; Reiner Benecke; Stefan Teipel; Stefan Vielhaber; Johannes Prudlo
Journal:  Neurobiol Aging       Date:  2013-08-28       Impact factor: 4.673

4.  Cortical surface-based analysis. I. Segmentation and surface reconstruction.

Authors:  A M Dale; B Fischl; M I Sereno
Journal:  Neuroimage       Date:  1999-02       Impact factor: 6.556

5.  The ALS-FTD-Q: a new screening tool for behavioral disturbances in ALS.

Authors:  Joost Raaphorst; Emma Beeldman; Ben Schmand; Joris Berkhout; Wim H J P Linssen; Leonard H van den Berg; Yolande A Pijnenburg; Hepke F Grupstra; Janneke G Weikamp; H Jurgen Schelhaas; Janne M Papma; John C van Swieten; Marianne de Visser; Rob J de Haan
Journal:  Neurology       Date:  2012-09-12       Impact factor: 9.910

6.  Impaired action knowledge in amyotrophic lateral sclerosis.

Authors:  M Grossman; C Anderson; A Khan; B Avants; L Elman; L McCluskey
Journal:  Neurology       Date:  2008-09-10       Impact factor: 9.910

7.  Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis.

Authors:  Michael J Strong; Gloria M Grace; Morris Freedman; Cathy Lomen-Hoerth; Susan Woolley; Laura H Goldstein; Jennifer Murphy; Christen Shoesmith; Jeffery Rosenfeld; P Nigel Leigh; Lucie Bruijn; Paul Ince; Denise Figlewicz
Journal:  Amyotroph Lateral Scler       Date:  2009-06

8.  A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD.

Authors:  Alan E Renton; Elisa Majounie; Adrian Waite; Javier Simón-Sánchez; Sara Rollinson; J Raphael Gibbs; Jennifer C Schymick; Hannu Laaksovirta; John C van Swieten; Liisa Myllykangas; Hannu Kalimo; Anders Paetau; Yevgeniya Abramzon; Anne M Remes; Alice Kaganovich; Sonja W Scholz; Jamie Duckworth; Jinhui Ding; Daniel W Harmer; Dena G Hernandez; Janel O Johnson; Kin Mok; Mina Ryten; Danyah Trabzuni; Rita J Guerreiro; Richard W Orrell; James Neal; Alex Murray; Justin Pearson; Iris E Jansen; David Sondervan; Harro Seelaar; Derek Blake; Kate Young; Nicola Halliwell; Janis Bennion Callister; Greg Toulson; Anna Richardson; Alex Gerhard; Julie Snowden; David Mann; David Neary; Michael A Nalls; Terhi Peuralinna; Lilja Jansson; Veli-Matti Isoviita; Anna-Lotta Kaivorinne; Maarit Hölttä-Vuori; Elina Ikonen; Raimo Sulkava; Michael Benatar; Joanne Wuu; Adriano Chiò; Gabriella Restagno; Giuseppe Borghero; Mario Sabatelli; David Heckerman; Ekaterina Rogaeva; Lorne Zinman; Jeffrey D Rothstein; Michael Sendtner; Carsten Drepper; Evan E Eichler; Can Alkan; Ziedulla Abdullaev; Svetlana D Pack; Amalia Dutra; Evgenia Pak; John Hardy; Andrew Singleton; Nigel M Williams; Peter Heutink; Stuart Pickering-Brown; Huw R Morris; Pentti J Tienari; Bryan J Traynor
Journal:  Neuron       Date:  2011-09-21       Impact factor: 17.173

9.  Behavior matters--cognitive predictors of survival in amyotrophic lateral sclerosis.

Authors:  William T Hu; Matthew Shelnutt; Ashley Wilson; Nicole Yarab; Crystal Kelly; Murray Grossman; David J Libon; Jaffar Khan; James J Lah; Allan I Levey; Jonathan Glass
Journal:  PLoS One       Date:  2013-02-27       Impact factor: 3.240

10.  Extramotor damage is associated with cognition in primary lateral sclerosis patients.

Authors:  Elisa Canu; Federica Agosta; Sebastiano Galantucci; Adriano Chiò; Nilo Riva; Vincenzo Silani; Andrea Falini; Giancarlo Comi; Massimo Filippi
Journal:  PLoS One       Date:  2013-12-05       Impact factor: 3.240

View more
  39 in total

Review 1.  The imaging signature of C9orf72 hexanucleotide repeat expansions: implications for clinical trials and therapy development.

Authors:  Stacey Li Hi Shing; Mary Clare McKenna; We Fong Siah; Rangariroyashe H Chipika; Orla Hardiman; Peter Bede
Journal:  Brain Imaging Behav       Date:  2021-01-05       Impact factor: 3.978

2.  Age at symptom onset influences cortical thinning distribution and survival in amyotrophic lateral sclerosis.

Authors:  Pilar M Ferraro; Corrado Cabona; Giuseppe Meo; Claudia Rolla-Bigliani; Lucio Castellan; Matteo Pardini; Matilde Inglese; Claudia Caponnetto; Luca Roccatagliata
Journal:  Neuroradiology       Date:  2021-03-04       Impact factor: 2.804

3.  Brain MRI shows white matter sparing in Kennedy's disease and slow-progressing lower motor neuron disease.

Authors:  Edoardo G Spinelli; Federica Agosta; Pilar M Ferraro; Giorgia Querin; Nilo Riva; Cinzia Bertolin; Ilaria Martinelli; Christian Lunetta; Andrea Fontana; Gianni Sorarù; Massimo Filippi
Journal:  Hum Brain Mapp       Date:  2019-03-28       Impact factor: 5.038

4.  Radial diffusivity as an imaging biomarker for early diagnosis of non-demented amyotrophic lateral sclerosis.

Authors:  Yifang Bao; Liqin Yang; Yan Chen; Biyun Zhang; Haiqing Li; Weijun Tang; Daoying Geng; Yuxin Li
Journal:  Eur Radiol       Date:  2018-06-08       Impact factor: 5.315

Review 5.  Neuroimaging in genetic frontotemporal dementia and amyotrophic lateral sclerosis.

Authors:  Suvi Häkkinen; Stephanie A Chu; Suzee E Lee
Journal:  Neurobiol Dis       Date:  2020-09-02       Impact factor: 5.996

Review 6.  Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria.

Authors:  Michael J Strong; Sharon Abrahams; Laura H Goldstein; Susan Woolley; Paula Mclaughlin; Julie Snowden; Eneida Mioshi; Angie Roberts-South; Michael Benatar; Tibor HortobáGyi; Jeffrey Rosenfeld; Vincenzo Silani; Paul G Ince; Martin R Turner
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2017-01-05       Impact factor: 4.092

7.  Perfusion alterations converge with patterns of pathological spread in transactive response DNA-binding protein 43 proteinopathies.

Authors:  Pilar M Ferraro; Charles Jester; Christopher A Olm; Katerina Placek; Federica Agosta; Lauren Elman; Leo McCluskey; David J Irwin; John A Detre; Massimo Filippi; Murray Grossman; Corey T McMillan
Journal:  Neurobiol Aging       Date:  2018-04-17       Impact factor: 4.673

8.  Neuroanatomical associations of the Edinburgh cognitive and Behavioural ALS screen (ECAS).

Authors:  Sneha Chenji; Abdullah Ishaque; Dennell Mah; Esther Fujiwara; Christian Beaulieu; Peter Seres; Simon J Graham; Richard Frayne; Lorne Zinman; Angela Genge; Lawrence Korngut; Wendy Johnston; Sanjay Kalra
Journal:  Brain Imaging Behav       Date:  2021-06       Impact factor: 3.978

9.  Primary lateral sclerosis and the amyotrophic lateral sclerosis-frontotemporal dementia spectrum.

Authors:  Smriti Agarwal; Elizabeth Highton-Williamson; Jashelle Caga; José M Matamala; Thanuja Dharmadasa; James Howells; Margaret C Zoing; Kazumoto Shibuya; Nimeshan Geevasinga; Steve Vucic; John R Hodges; Rebekah M Ahmed; Matthew C Kiernan
Journal:  J Neurol       Date:  2018-06-04       Impact factor: 4.849

10.  UNC13A polymorphism contributes to frontotemporal disease in sporadic amyotrophic lateral sclerosis.

Authors:  Katerina Placek; G Michael Baer; Lauren Elman; Leo McCluskey; Laura Hennessy; Pilar M Ferraro; Edward B Lee; Virginia M Y Lee; John Q Trojanowski; Vivianna M Van Deerlin; Murray Grossman; David J Irwin; Corey T McMillan
Journal:  Neurobiol Aging       Date:  2018-09-27       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.